SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway–Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)
Charu Aggarwal, Mary W. Redman, Primo N. Lara, Hossein Borghaei, Philip Hoffman, Jeffrey D. Bradley, Alfred J. Newman, Marvin J. Feldman, Katherine Minichiello, Jieling Miao, Philip C. Mack, Vassiliki A. Papadimitrakopoulou, Roy S. Herbst, Karen Kelly, David R. Gandara
Dive into the research topics of 'SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway–Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)'. Together they form a unique fingerprint.